Corpus Intelligence Market Analysis — LA EXTENDED CARE OF LAFAYETTE 2026-04-26 06:38 UTC
Market Analysis — LA EXTENDED CARE OF LAFAYETTE
LA market | 7 hospitals | HHI: 5,330 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
7
Hospitals in Market
609
Total Beds
$0.7B
Market Revenue
Concentrated
HHI: 5,330
None
Moat Rating (1/10)
#3
Market Share Rank

Competitive Moat (Mauboussin Framework)

Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).

Scale Advantageweak
Switching Costslow
Market Share2.6%
Top 3 Concentration94.7%
Network Density1.15
Margin vs Market+0.5%
Bed Util vs Market-2.3%

What This Means

This hospital has a none moat — no moat — commoditized market position, pricing power limited. The LA market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 5,330).

Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full LA market.

Top Competitors

HospitalBedsRevenueRev ShareBed Share
LAFAYETTE GENERAL MEDICAL CENTER390$480M69.2%64.0%
UNIVERSITY HOSPITAL & CLINICS52$159M22.9%8.5%
LTAC OF LOUISIANA LLC18$12M1.7%3.0%
LAFAYETTE PHYSICAL REHAB32$12M1.7%5.2%
OCEANS BEHAVIORAL HOSPITAL OF LAFAYE38$11M1.6%6.2%
SAGE SPECIALTY & REHAB OF LAFAYETTE31$2M0.3%5.1%

Regional Payer Mix

■ Medicare 47%■ Medicaid 8%■ Commercial 45%